Point Biopharma

About:

Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.

Website: https://www.pointbiopharma.com/

Twitter/X: pointbiopharma

Top Investors: Perceptive Advisors, RA Capital Management, Fairmount Funds Management, Farallon Capital Management, Johnson & Johnson Innovation – JJDC

Description:

POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177), manufacturing technology and novel direct-to-patient targeting to revolutionize theragnostic drug development and radioligand commercialization.